Forbes July 14, 2025
William A. Haseltine

In Destiny’s Child No Longer: Rewriting Genetic Fate, we envisioned a world where every newborn would be screened for genetic risks. We see a future in which the randomness of genetic inheritance could be met with knowledge, preparation, and, ultimately, intervention. Today, that vision is rapidly becoming reality on both sides of the Atlantic.

The United Kingdom’s National Health Service (NHS) has announced a landmark plan to offer whole genome sequencing to every newborn. At the same time, Florida’s Sunshine Genetics Act has set the stage for a statewide pilot of newborn genomic screening. These developments are a shift in public health. They stand to transform the diagnosis, prevention, and treatment of rare diseases for generations to come.

The UK’s...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Pharma / Biotech, Precision Medicine
JPM 2026: Genoa Ventures’ Jenny Rooke on Next-Gen Clinical Assessment Tools
From Early Detection to Targeted Therapy: How AI is Reframing Precision Medicine
How Precision Medicine and AI are Evolving: An MD Anderson Perspective
Bringing Precision Medicine Into the Home
Inside the Virtual Cell: New Depths for Precision Medicine

Share Article